Src tyrosine kinase promotes cardiac remodeling induced by chronic sympathetic activation

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Cardiac remodeling is central to cardiovascular disease pathogenesis.
• Excessive beta-adrenergic receptor (β-AR) activation is a known driver of cardiac remodeling.
• The precise molecular mechanisms of β-AR-induced cardiac remodeling are not fully understood.

Purpose of the Study:

• To identify key molecular players in β-AR-induced cardiac remodeling.
• To elucidate the role of Src tyrosine kinase in this process.
• To investigate the therapeutic potential of targeting Src.

Main Methods:

• In vivo studies using isoproterenol (ISO) to induce cardiac remodeling.
• In vitro experiments on cardiac fibroblasts and cardiomyocytes.
• Analysis of the β-AR/Src/ERK signaling pathway.

Main Results:

• Src tyrosine kinase was identified as a mediator of ISO-induced cardiac hypertrophy, fibrosis, and inflammation in vivo.
• Src facilitated β-AR-mediated proliferation and transdifferentiation of cardiac fibroblasts and hypertrophy of cardiomyocytes in vitro.
• Src mediates the activation of the extracellular signal-regulated protein kinase (ERK1/2) pathway by β-AR.

Conclusions:

• Src tyrosine kinase significantly promotes β-AR-induced cardiac remodeling.
• The β-AR/Src/ERK signaling pathway is crucial for cardiac remodeling in cardiac fibroblasts.
• Src represents a potential therapeutic target for mitigating cardiac remodeling.